Body
Composition
Summary prepared by Mary Fran Sowers in collaboration with
the Allostatic Load working group. Last revised 1997.
Table of Contents
a. Introduction and Rationale
b. Methodology
c. Waist-Hip Ratio
d. Cortisol
e. Female Sex Steroid Hormones
f. References
Introduction and Rationale
It is increasingly well appreciated that body composition
and body composition topology are related to disease conditions. This has been shown with
heart disease, diabetes, gall bladder disease, certain cancers, osteoporosis, and
arthritis (see Sowers, 1996).
In field based studies, measures of body composition have historically been limited to
simple measures such as weight adjusted for various height power indices as measures of
adiposity. An example of this is the body mass index (Quetelet index) which is weight
divided by the square of height. While weight adjusted for height is highly correlated
with the amount of fat mass (correlations of 0.80 to 0.90), this is a notoriously poor
approach for the measurement of muscle mass, protein status or lean tissues. The
importance of the lean compartment has now been shown to be a better predictor of bone
mass and its change. It is in the lean compartment that metabolism of glucose takes place
and where insulin resistance is manifest.
Methodology
This section will describe methodologies for three
approaches to body composition. The first method, underwater densitometry, refers to the
classic approach to determining body composition based on principles promulgated by
Archimedes. While not feasible for field studies, it is the approach, which until the last
5 years, served as the gold standard for validating other methods (Siri, 1956 and 1961;
Brozek, 1963). The second methodology, dual x-ray densitometry (DXA), is rapidly replacing
underwater weighing as the gold standard for body composition and is logistically more
viable than is underwater weighing (Cullum et al., 1989; Mazess et al., 1989; Kelly et
al.,1988). The third methodology, electrical impedance, is highly viable in field settings
and has the capacity for describing the distribution of the water compartment in various
diseases. This information can then be used to estimate amounts of fat and lean (Lukaski
and Bolonchuk, 1988).
Table 1. Ranking of Methods for
Assessment of Skeletal Muscle Mass in Human Beings
| Method |
Site |
Precision |
Accuracy |
Utility |
Cost |
| Anthropometry |
R, WB |
3 |
? |
4 |
1 |
| Creatinine |
WB |
2 |
2 |
1 |
3 |
| 3-Methyl Histidine |
WB |
2 |
2 |
1 |
4 |
Computed
Tomography |
R, WB |
5 |
4 |
4 |
5 |
Magnetic
Resonance |
R, WB |
5 |
4 |
4 |
5 |
| DXA |
R, WB |
5 |
4 |
4 |
4 |
Total Body
Potassium |
WB |
4 |
2 |
1 |
5 |
| Blood |
R |
4 |
? |
4 |
1 |
Ranking system: ascending scale, 1 = least and 5 =
greatest
R = regional and WB = whole-body assessment.
The term densitometry refers to general procedures
of estimating body composition from body density, under the assumption that the density of
any material is the function of the proportion and densities of its components. Until
recently, body composition was characterized by underwater weighing
which generated knowledge of two compartments, the fat and the fat-free masses. The fat
free mass is a heterogeneous compartment which could be further subdivided according to
its primary constituents: water (73.8%), protein (19.4%), and mineral (7.8%).
The underlying assumptions of this kind of body composition were as follows:
- The densities of each of the constituent compartments was additive.
- The densities of each of the compartments was relatively constant from person to person.
- The proportions of the fat-free mass compartment (i.e., of water, protein and mineral)
were relatively constant.
- That there would not be extensions to highly non-heterogeneous populations.
Since the 1940s, numerous techniques to estimate body
composition have been developed, with the primary gold standard for estimation being the underwater
weighing technique methods (Siri, 1956 and 1961; Brozek, 1963). This approach has a
number of technical and logistical limitations.

The technique, which is grounded in the determination of fat mass and then calculates
the fat-free mass by extension, is estimated to have an error of approximately 4% when
relatively homogenous populations are studied (Akers and Buskirk, 1969). While the
requirements for calculation are not necessarily complex, accurate data require highly
standardized implementation and facilities which are not widely available. Furthermore, a
major limitation is that the technique requires a highly motivated participant who is
willing to don bathing attire, complete effective spirometry, is willing and capable of
exhaling prior to submersion in a water tank and can be confident in that tank for a
period of 30 seconds.
With the development of dual photon and dual x-ray densitometry (DXA) in the
late 1980s and early 1990s, another approach was available (Cullum et al.,
1989; Mazess et al., 1989;1992). The estimated fat content in bone-free lean tissue is
derived by the constant attenuation of pure fat (Rf = 1.18-1.21) and the
attenuation of bone-free lean tissue (Rl = 1.399). Given the constancy of these
two values from subject to subject, the ratio of the attenuation at the lower energy
relative to the higher energy in soft tissue for the low and high energy x-rays (40 keV
and 70 keV) is a function of the proportion of the R values for fat and lean in each
pixel.
The relative ease of access to dual x-ray densitometry has revolutionized the capacity
to undertake body composition studies. The implementation is relatively simple and takes
minimal cooperation from the participant. Nonetheless, there are still issues which must
be addressed.
a. Dual x-ray densitometry cannot be undertake in the morbidly obese for two reasons.
First, the table is only mechanically stable to weights between 260-290 pounds (depending
upon the manufacturer), but deforms with loads beyond those weights, jeopardizing the
entire system. Secondly, an assumption underlying the use of DXA assumes that measurements
are not affected by the anteroposterior thickness of the body. Consistently studies have
shown that thickness greater than 25 cm has an effect, violates the assumption, and
typically overestimates the fat mass (Laskey et al., 1992).
b. The sensitivity to change in hydration status has the potential to affect the
bone-free lean tissue; however, studies indicate that this is a relatively minor source of
error (Going et al., 1993).
c. The estimation of body composition is a function of the 40-50% of the pixels which
do not contain bone. Thus, measurement of regions of the body including thorax and arm
which may have relatively fewer pixels without bone are more prone to measurement error.

A third technique is electrical impedance (BIA). All BIA devices consist of
essentially an alternating electrical current source (usually about 1/4 volt), cables and
electrodes for inducing the current into the body and for sensing the voltage drop due to
impedance from body tissues and a system for measuring impedance.
This approach operates under the assumption that the electronic conduction in
biological tissues is mainly ionic, that is, electrical charges are transferred by ionized
salts, bases and acids dissolved in body fluids. Thus, simplistically conceived, the body
has highly conductive intracellular and extracellular materials which are separated by
insulating layers of materials such as lipids which can be measured. The measures
generated by the technique, which are resistance and reactance, can then be used to derive
estimates of body water and, by extension, lean tissue and fat mass. (Boulier et al,
1990). The electrical impedance approach has several notable characteristics.
- It does not require the cumbersome apparatus that is associated with both underwater
weighing and to a lesser degree, DXA.
- While there have been some reports that BIA predicts fat-free mass less well at the
extremes of body fatness (Gray et al., 1989), this limitation is less universal than with
underwater weighing and with DXA.
Because there is less experience in the direct measurement of total body water and the
derived body composition from intracellular and extracellular fluid, the normative data
and interpretative value of BIA has not expanded as rapidly as it has for DXA.
Waist/Hip Ratio
The ratio between waist circumference and hip circumference
if often used as an index of the distribution of adipose tissue, although this ratio is
influenced by some other body tissues. The utility of the waist/hip ratio (WHR) as an
indicator of relative adipose tissue distribution in children and youth is not
established, but it is useful in adults. Percentiles are available for the WHR in a large
French sample (8,646 males; 9,747 females) 17 to 60 years of age (Tichet et al., 1993) and
a large Danish sample (1,527 males; 1,467 females) 35 to 65 years of age (Heitmann, 1991).
WHRs of middle-aged women are influenced by menopausal status. Mean ratios change
slightly from premenopause (0.73 + 0.05, n = 550, 43.4 + 3.9 years) to
perimenopause (0.74 + 0.06, n = 168, 49.2 + 3.8 years) but increase
significantly after menopause (0.78 + 0.06, n = 1133, 58.6 + 4.7 years)
(Sonnenschein, Kim, Pasternack, & Toniolo, 1993). An elevated WHR is usually accepted
as an indication of proportionally more abdominal adipose tissue, but the accuracy of the
WHR in distinguishing abdominal visceral adipose tissue from saturated adipose tissue is
not defined. In obese individuals, changes in visceral adipose tissue after weight loss
are not related to changes in the WHR (van der Kooy et al, 1993).
Among adults, mean WHRs are larger in Mexican American than in White females from San
Antonio, Texas, but are slightly larger in White than in Mexican American males. WHRs of
young adult Black and White women and men in the U.S. differ only slightly (Kaye et al,
1993; Slattery et al, 1992). Among older American Blacks in
men (35 years), WHR is similar to that of Europeans while the mean WHR for Black females
is markedly larger than Europeans (Croft et al, 1993).
In the San Antonio sample, there is a significant social class difference in the WHR
among Mexican American males but not among females. The age-adjusted ratio in males
increases from 0.92 in barrio residents (low SES) to 0.94 in residents from a transitional
neighborhood to 0.95 in suburban residents (high SES). Corresponding age-adjusted means in
Mexican American females are, respectively, 0.84, 0.83, and 0.84. In contrast, the WHR
does not show a significant social class difference among White males and females in San
Antonio (Malina and Stern, 1992).
Though not differentiating between saturated adipose tissue and visceral adipose
tissue, estimates of android (upper body segment, trunk) and gynoid (hip and thigh region)
distributions of adipose tissue from total body DXA scans indicate the sex difference and
changes in relative adipose distribution associated with menopause. The proportion of
android adipose tissue is greater in postmenopausal women, while the proportion of gynoid
adipose is greater in premenopausal women. In both groups of women, however, the
proportion of android fat is less than in men. Thus, with the transition to menopause, the
relative adipose distribution of women changes in the direction of that observed in men
(Ley, Lees, & Stevenson, 1992).
Estimates of abdominal visceral adipose tissue and saturated adipose tissue areas
increase with greater body mass index (BMI). Overweight women have proportionally more
saturated adipose tissue than normal weight females until about 60 years of age, after
which they have proportionally more visceral adipose tissue (Enzi et al, 1986).
Cortisol
Excess cortisol secretion and its consequences are clearly
seen in Cushings syndrome as a wasting of lean body mass, particularly muscle. Body
fat mass and distribution are also changed. Clinical evidence suggests that the changes in
adipose tissue are dependent on the prevailing insulin concentrations. These in turn are
determined by the insulin resistance, created by the glucocorticoid excess. Therefore, the
interactions of insulin become important for the net effect of glucocorticoids on muscle
mass as well as on adipose tissue mass and distribution. This is why body composition of
both lean and fat mass are needed.
Glucocorticoids probably exert direct effects on the insulin sensitivity of both liver
and muscle (Baxter & Rosseau, 1979; McMahon, Gerich, & Rizza, 1988). It has been
hypothesized that these effects are mediated via free fatty acids (FFA) in studies with
rats under stress (Guillaume-Gentil, Assimacopoulos-Jeannet, Jeanrenaud, 1993). The
consequences were insulin resistance of hepatic gluconeogenesis as well as of glucose
metabolism in muscles. These perturbations were obliterated by the administration of an
inhibitor of fatty acid oxidation. These results suggest that the effects of
glucocorticoids on the mobilization of FFA from adipose tissue are of primary importance
for the insulin resistance of that condition in the integrated system. The important
regulatory effects of insulin would, in conditions with cortisol excess in vivo, be
expected to be a balance between a slight inhibition of lipolysis and a blunted
antilipolytic effect of insulin.
There are complex interactions between steroid and peptide hormones in the regulation
of adipose tissue metabolism and the subsequent effects on body fat mass. In the condition
of excess cortisol secretion of central origin, sex steroid secretion is probably
inhibited through interactions by corticotropin releasing factor (CRF) on gonadotropin
releasing hormone (Olsen & Ferin, 1987). Therefore the net effects will mainly be
those of cortisol and insulin, whereas the effects of GH and sex steroid hormones are less
evident, which contributes to the total effect of cortisol excess on body fat due to
central inhibitory mechanisms.
Glucocorticoids also exert marked effects on lipid mobilization in adipose tissue with
interactive effects by other hormones. Fain, Kovacev, and Scow (1965) showed that
glucocorticoids, particularly in the presence of GH, act by increasing lipid mobilization
in vitro in adipose tissue from rats. It is important to interpret the results in relation
to the species studied. In human adipose tissue, the acute short-term effects of cortisol
appear to be absent. In long-term (days) experiments under fully controlled conditions,
the effects are easier to detect. In the presence of insulin, cortisol has a weak
inhibitory effect on catecholamine-induced lipolysis, but cortisol induces a marked
"permissive" effect by GH on lipolysis (Cigolini & Smith, 1979; Ottosson,
Lönnroth, Björntorp, & Edén, 1995).
Mobilization of triglycerides from adipose tissue is dependent not only on lipolysis
but also on the capacity of the adipocyte to re-esterify FFA. There is evidence that
glucocorticoids may inhibit this process by interactions with glucose transport into
adipocytes (Carter-Su & Okamoto, 1987), glucose being obligatory for
re-esterification.
The net effects of glucocorticoids on lipid mobilization in vivo have been found to
result in marked increases of circulating FFA both in man (Divertie, Jensen, & Miles,
1991) and rats (Guillaume-Gentil et al, 1993). Studies in vitro of adipose tissue from
patients suffering from Cushings syndrome with hyperinsulinemia have shown that the
lipolytic sensitivity to catecholamine is unchanged or inhibited (Rebuffé-Scrive,
Krotkiewski, Elfverson, & Björntorp, 1988). The elevated FFA concentrations after
cortisol excess may be due either to a weak antilipolytic effect of insulin or an
inhibited glucose transport, leading to diminished fatty acid re-esterification in adipose
tissue, or a combination of both. Again, as with LPL regulation, sex steroid hormones may
interfere with several of these regulatory steps of FFA mobilization. In states of
hypercortisolemia, however, the secretion of sex steroid hormones is decreased, minimizing
such effects, which, however, probably play important roles in the normal situation,
particularly in young adults with intact sex steroid hormone secretion.
Steroid hormones usually exert their effects via interaction with specific receptors
for subsequent interactions of the hormone-receptor complex at the level of the
appropriate genes. A glucocorticoid receptor (GR) has been described in adipose tissue
from rats (Feldman & Loose, 1977) and human beings (Rebuffé-Scrive, Lundholm, &
Björntorp, 1985b). The density of this receptor seems to vary in different regions of
adipose tissue, and there is evidence that the density is higher in intra-abdominal
(visceral) than in subcutaneous adipose tissues in studies with ligand binding in cytosol
preparations in man (Rebuffé-Scrive et al, 1985b) and in intact cells in rats (Sjögren,
Weck, & Björntorp, 1994). Also, the steady state GR mRNA levels have been reported to
be higher in visceral than subcutaneous adipose tissue in man (Rebuffé-Scrive et al,
1990; Peeke et al, 1993).
The effects of glucocorticoids on adipose tissue appear to be regionally specific as
shown in Cushings syndrome, where there is marked redistribution of storage fat from
the periphery to central depots. There are several possible reasons for this. For example,
there is a high density of the GR in this depot (Rebuffé-Scrive et al, 1985b, 1990;
Sjögren et al, 1994) or the balance between lipid accumulation and mobilization are
disturbed, with more pronounced effects of the former.
Other conditions with long-term exposure to excess glucocorticoids are followed by
redistribution of adipose tissue, having been described in the treatment of asthma and
rheumatoid arthritis with glucocorticoids (Krotkiewski, Blohmé, Lindholm, &
Björntorp, 1976b). Marin has suggested that obesity, with disproportional increase of
visceral fat depots, is a condition with increased cortisol secretion due to a high
sensitivity of the hypothalamic-adrenal axis to different forms of stress (Marin et al,
1992).
Female Sex Steroid Hormones
Female sex steroid hormone concentrations also regulate
adipose tissue mass, although it is not clear whether these effects are direct or mediated
via energy intake and/or expenditure (Wade & Gray, 1979). With menopause, an increase
in visceral fat mass is preventable by hormonal replacement therapy (Haarbo, Marskew,
Gottfredsen, & Christiansen, 1991; Rebuffé-Scrive, Eldh, Hafström, & Björntorp,
1986). Furthermore, the re is some evidence of enlargement of femoral subcutaneous
adipocytes to support the demands of pregnancy and lactation and this enlarge is reported
to disappear with menopause (Rebuffé-Scrive et al, 1985a). Progesterone competes with the
GR (Rebuffé-Scrive et al, 1985b; Xu, Hoebeke, & Björntorp, 1990b) and may protect
from glucocorticoid effects during the late luteal phase of the menstrual cycle.
In summary, there are substantial reasons to believe that both measures of body
composition and body topology are important is states associated with higher corticalism,
growth hormone interactions and sex steroid levels. To the degree that these hormone
interactions are contributory to allostatic load, body composition and body topology is
contributory to allostatic load. Furthermore, the recent development of technology which
provides highly precise and logistically feasible measures of lean tissue and adipose
tissue as well as its relative anatomic location suggest that it is possible to generate
research in this area relative to allotstatic load.
References
- Akers R, Buskirk ER (1969) An underwater weighing system utilizing "force
cube" transducers. J Appl Physiol 26:649-652.
- Brozek J, Grande F, Anderson JT, et al (1963) Densitometric analysis of body
composition: Revision of some quantitative assumptions. Annals New York Academy Sciences
110:113-140.
- Siri WE (1956) The gross composition of the body. In C.A. Tobias & J.H. Lawrence
(Eds.), Advances in biological and medical physics (vol. 4, pp. 239-280). New York:
Academic.
- Siri WE (1961) Body composition from fluid spaces and density: Analysis of methods. In
J. Brozek & A. Henschel (Eds.), Techniques for measuring body composition (pp.
223-224). Washington, DC: National Academy of Sciences, National Research Council.
- Cullum ID, Ell PJ, & Ryder JR (1989) X-ray dual photon absorptiometry: A new method
for the measurement of bone density. Br J Radiol 62:587-592.
- Going SB, Massett MP, Hall MC, et al (1993) Detection of small changes in body
composition by dual-energy x-ray absorptiometry. Am J Clin Nutr 57:845-850.
- Hansen NJ, Lohman TG, Going SB, et al (1993) Prediction of body composition in
premenopausal females from dual-energy x-ray absorptiometry. J Appl Physiol 75:1637-1641.
- Mazess RB, Peppler WW, Chestnut CH III, et al (1981) Total body bone mineral and lean
body mass by dual-photon absorptiometry, II: Comparison with total body calcium by neutron
activisceral adipose tissueion analysis. Calcif Tiss Intl 33:361-363.
- Mazess RB, Peppler WW, Gibbons M (1984) Total body composition by dual-photon (153Gd)
absorptiometry. Am J Clin Nutr 40:834-839.
- Mazess RB, Trempe JA, Bisek JP, et al (1991) Calibration of dual-energy x-ray
absorptiometry for bone density. J Bn Miner Res 6:799-806.
- Boulier A, Fricker J, Thomasset A, Apfelbaum M (1990) Fat-free mass estimation by the
two-electrode impedance method. Am J Clin Nutr 52:581-585.
- Chumlea WC, Guo S, Baumgartner RN, Siervogel RM (1993b) Determination of body fluid
compartments with multiple frequency bioelectrical impedance. In K.J. Ellis & J.D.
Eastman (Eds.), Human body composition (pp. 23-26). New York: Plenum.
- Cochran WJ, Fiorotto ML, Sheng HP, Klish WJ (1989) Reliability of fat-free mass
estimates derived from total body electrical conductivity measurements as influenced by
changes in extracellular fluid volume. Am J Clin Nutr 49:29-32.
- Cornish BH, Thomas BJ, Ward LC (1993) Improved prediction of extracellular and total
body water using impedance loci generated by multiple frequency bioelectrical impedance
analysis. Physics Med Biol 38:337-346.
- Davies PSW, Preece MA, Hicks CJ, et al (1988) The prediction of total body water using
bioelectrical impedance in children and adolescents. Annal Hum Biol 15:237-240.
- Deurenberg P, Schouten FJM (1992) Loss of total body water and extracellular water
assessed by multifrequency impedance. Eur J Clin Nutr 46:247-255.
- Deurenberg P, van der Kooy K, Leenen R, et al (1991) Sex and age specific prediction
formulas for estimating body composition from bioelectrical impedance: A cross-validation
study. Intl J Obesity 15:17-25.
- Kushner RF (1992) Bioelectric impedance analysis: A review of principles and
applications. J Am Coll Nutr 11:199-209.
- Kushner RF, Schoeller DA (1986) Estimation of total body water by bioelectrical
impedance analysis. Am J Clin Nutr 44:417-424.
- Kushner RF, Schoeller DA, Fjeld CR, Danford L (1992) Is the impedance index (ht2/R)
significant in predicting total body water? Am J Clin Nutr 56:835-839.
- Lukaski HC, Bolonchuk WW (1988) Estimation of body fluid volumes using tetrapolar
bioelectrical impedance measurements. Aviation Space & Environmental Medicine
59:1163-1169.
- Lukaski HC, Bolonchuk WW, Hall CB, Siders WA (1986) Validation of tetrapolar
bioelectrical impedance method to assess human body composition. J Appl Physiol
60:1327-1332.
- Tichet J, Vol S, Balkau B, et al (1993) Android fat distribution by age and sex: The
waist hip ratio. Diabete et Metabolisme 19:273-276.
- Heitmann BL (1991) Body fat distribution in the adult Danish population aged 35-65
years: An epidmeiological study. Intl J Obesity 15:535-545.
- Sonnenschein EG, Kim MY, Pasternack BS, Toniolo PG (1993) Sources of variability in
waist and hip measurements in middle-aged women. Am J Epidemiol 138:301-309.
- van der Kooy K, Leenen R, Seidell JC, et al (1993) Waist-hip ratio is a poor predictor
of changes in visceral fat. Am J Clin Nutr 57:327-333.
- Kaye SA, Folsom AR, Jacobs DR Jr., et al (1993) Psychosocial correlates of body fat
distribution in Black and White young adults. Intl J Obesity 17:271-277.
- Slattery ML, McDonald A, Bild DE, et al (1992) Associations of body fat and its
distribution with dietary intake, physical activity, alcohol, and smoking in Blacks and
Whites. Am J Clin Nutr 55:943-949.
- Croft JB, Strogatz DS, Keenan NL, et al (1993) The independent effects of obesity and
body fat distribution on blood pressure in Black adults: The Pitt County Study. Intl J
Obesity 17:391-397.
- Malina RM, Stern MP (1992) [The San Antonio Heart Study]. Unpublished raw data.
- Ley CJ, Lees B, Stevenson JC (1992) Sex- and menopause-associated changes in body fat
distribution. Am J Clin Nutr 55:950-954.
- Enzi G, Gasparo M, Biondetti PR, et al (1986) Subcutaneous and visceral fat distribution
according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr
44:739-746.
- Baxter JD, Rosseau GG (1979) Glucocorticoid hormone action. Endocrinol 12:1-26.
- McMahon M, Gerich J, Rizza J (1988) Effects of glucocorticoids on carbohydrate
metabolism. Diabetes & Metabolic Reviews 4:17-30.
- Guillaume-Gentil C, Assimacopoulos-Jeannet F, Jeanrenaud B (1993) Involvement of
non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin
resistance in vivo in rats. Diabetologia 36:899-906.
- Olsen D, Ferin M (1987) Corticotropin-releasing hormone inhibits gonadotropin secretion
in ovariectomized Rhesus monkey. J Clin Endocrinol Metabol 65:262-267.
- Fain JN, Kovacev VP, Scow RO (1965) Effect of growth hormone and dexamethason on
lipolysis and metabolism in isolated fat cells of the rat. J Biological Chemistry
240:3522-3529.
- Cigolini M, Smith U (1979) Human adipose tissue in culture, VIII: Studies on the
insulin-antagonistic effect of glucocorticoids. Metabolism 28:502-510.
- Ottosson M, Lönnroth P, Björntorp P, Edén S (1995) Differential effects of cortisol
and growth hormone on lipolysis in human adipose tissue. Manuscript submitted for
publication.
- Carter-Su C, Okamoto K (1987) Effect of insulin and glucocorticoids on glucose
transporters in rat adipocytes. Am J Physiol 252:E441-E453.
- Divertie G, Jensen M, Miles J (1991) Stimulation of lipolysis in humans by physiological
hypercortisolemia. Diabetes 40:1228-1232.
- Rebuffé-Scrive M, Krotkiewski M, Elfverson J, Björntorp P (1988) Muscle and adipose
tissue morphology and metabolism in Cushings syndrome. J Clin Endocrinol Metabol
67:1122-1128.
- Feldman D, Loose G (1977) Glucocorticoid receptors in adipose tissue. Endocrinol
100:389-405.
- Rebuffé-Scrive M, Lundholm K, Björntorp P (1985b) Glucocorticoid hormone binding to
human adipose tissue. Eur J Clin Invest 15:267-272.
- Sjögren J, Weck M, Nilsson A, Ottosson M, Björntorp P (1994) Glucocorticoid binding to
rat adipocytes. Biochim Biophys Acta 1224:17-21.
- Rebuffé-Scrive M, Brönnegard M, Nilsson A, et al (1990) Steroid hormone recepotrs in
human adipose tissues. J Clin Endocrinol Metabol 71:1215-1219.
- Peeke P, Oldfield E, Alexander R, et al (1993) Glucocorticoid receptor protein in
omental and subcutaneous adipose tissue of patients with Cushing syndrome prior to and
after surgical cure. Obesity Research 1 (suppl 2) Abstract No. 49.
- Krotkiewski M, Blohme B, Lindholm N, Björntorp P (1976b) The effects of adrenal
corticosteroids on regional adipocyte size in man. J Clin Endocrinol Metabol 42:91-97.
- Marin P, Darin N, Amemiya T, et al (1992) Cortisol secretion in relation to body fat
distribution in obese premenopausal women. Metabol 41:882-886.
- Wade GN, Gray JM (1979) Gonadal effects on food intake and adiposity: A metabolic
hypothesis. Physiol Behavior 22:583-593.
- Haarbo J, Marskew U, Gottfredsen A, Christiansen C (1991) Postmenopausal hormone
replacement therapy prevents central distribution of body fat after menopause. Metabol
40:323-326.
- Rebuffé-Scrive M, Eldh J, Hafström L-O, Björntorp P (1986) Metabolism of mammary,
abdominal and femoral adipocytes in women before and after menopause. Metabol 35:792-797.
- Rebuffé-Scrive M, Enk L, Crona N, et al (1985a) Fat cell metabolism in different
regions in women: Effect of menstrual cycle, pregnancy, and lactation. J Clin Invest
75:1973-1976.
- Xu X, Hoebeke J, Björntorp P (1990b) Progestin binds to the glucocorticoid receptor and
mediates antiglucocorticoid effect in rat adipose precursor cells. J Steroid Biochem
36:465-471.
|